Dimethylacetamide








































































































































































































Dimethylacetamide

Skeletal formula of dimethylacetamide

Ball and stick model of dimethylacetamide
Names

Preferred IUPAC name

N,N-Dimethylacetamide

Identifiers

CAS Number



  • 127-19-5 ☑Y


3D model (JSmol)


  • Interactive image

Abbreviations
DMA, DMAC, DMAc[1]

Beilstein Reference

1737614

ChEBI


  • CHEBI:84254 ☒N


ChEMBL


  • ChEMBL11873 ☑Y


ChemSpider


  • 29107 ☑Y


ECHA InfoCard

100.004.389

EC Number
204-826-4

MeSH

dimethylacetamide


PubChem CID


  • 31374


RTECS number
AB7700000

UNII


  • JCV5VDB3HY ☑Y





Properties

Chemical formula


C4H9NO

Molar mass

7001871220000000000♠87.122 g·mol−1
Appearance
Colorless liquid

Odor
Ammoniacal

Density
0.937 g mL−1

Melting point
−20 °C (−4 °F; 253 K)

Boiling point
165.1 °C; 329.1 °F; 438.2 K

Solubility in water

Miscible

log P
−0.253

Vapor pressure
300 Pa

UV-vis (λmax)
270 nm


Refractive index (nD)

1.4375

Viscosity
0.945 mPa s [2]
Thermochemistry


Heat capacity (C)

178.2 J K−1 mol−1


Std enthalpy of
formation fHo298)

−300.1 kJ mol−1


Std enthalpy of
combustion cHo298)

−2.5835–−2.5805 MJ mol−1
Hazards

GHS pictograms

The exclamation-mark pictogram in the Globally Harmonized System of Classification and Labelling of Chemicals (GHS)The health hazard pictogram in the Globally Harmonized System of Classification and Labelling of Chemicals (GHS)

GHS signal word

DANGER

GHS hazard statements


H312, H319, H332, H360

GHS precautionary statements


P280, P308+313

NFPA 704



Flammability code 2: Must be moderately heated or exposed to relatively high ambient temperature before ignition can occur. Flash point between 38 and 93 °C (100 and 200 °F). E.g., diesel fuel
Health code 2: Intense or continued but not chronic exposure could cause temporary incapacitation or possible residual injury. E.g., chloroform
Reactivity code 0: Normally stable, even under fire exposure conditions, and is not reactive with water. E.g., liquid nitrogen
Special hazards (white): no code
NFPA 704 four-colored diamond


2


2


0



Flash point
63 °C (145 °F; 336 K)

Autoignition
temperature

490 °C (914 °F; 763 K)

Explosive limits
1.8–11.5%
Lethal dose or concentration (LD, LC):


LD50 (median dose)

2.24 g kg−1(dermal, rabbit)
4.3 g kg−1(oral, rat)
4.8 g/kg (oral, rat)
4.62 g/kg (oral, mouse)[4]


LC50 (median concentration)

2475 ppm (rat, 1 hr)[4]
US health exposure limits (NIOSH):


PEL (Permissible)

TWA 10 ppm (35 mg/m3) [skin][3]


REL (Recommended)

TWA 10 ppm (35 mg/m3) [skin][3]


IDLH (Immediate danger)

300 ppm[3]
Related compounds

Related compounds



  • dimethylformamide

  • acetamide

  • methylpyrrolidone



Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).


☒N verify (what is ☑Y☒N ?)

Infobox references



Dimethylacetamide (DMAc or DMA) is the organic compound with the formula CH3C(O)N(CH3)2. This colorless, water-miscible, high boiling liquid is commonly used as a polar solvent in organic synthesis. DMA is miscible with most other solvents, although it is poorly soluble in aliphatic hydrocarbons.




Contents






  • 1 Synthesis, reactions, applications


  • 2 Toxicity


  • 3 Regulation


  • 4 References


  • 5 External links





Synthesis, reactions, applications


DMA is prepared by the reaction of dimethylamine with acetic anhydride or esters of acetic acid. Dehydration of the salt of dimethylamine and acetic acid also furnishes this compound:[5]


CH3CO2H·HN(CH3)2 → H2O + CH3CON(CH3)2

The chemical reactions of dimethylacetamide are typical of N,N-disubstituted amides. It will hydrolyze in the presence of acids:


CH3CON(CH3)2 + H2O + HCl → CH3COOH + (CH3)2NH2+Cl

It is however resistant to bases. For this reason DMA is useful solvent for reactions involving strong bases such as sodium hydroxide.[6]


Dimethylacetamide is commonly used as a solvent for fibers (e.g., polyacrylonitrile, spandex) or in the adhesive industry.[5] It is also employed in the production of pharmaceuticals and plasticizers as a reaction medium. It is an important Lewis base used to establish the ECW model.


Dimethylacetamide is also used as an excipient in drugs, e.g. in Vumon (teniposide), Busulfex (busulfan) or Amsidine (amsacrine).



Toxicity


Dimethylacetamide is a medium potency reproductive toxicant (toxic for reproduction, category 1B)[7] and may damage fertility or the unborn child. It is harmful in contact with skin or if inhaled, and causes serious eye irritation.


Dimethylacetamide can cause hepatotoxicity, including occupational dimethylacetamide exposure-induced hepatotoxicity.[8][9][10][11] At high doses (400 mg/kg bodyweight daily), dimethylacetamide causes effects on the central nervous system (e.g. depression, hallucinations and delusion).[8][12][13]


Dimethylacetamide may be incompatible with polycarbonate or ABS. Devices (e.g. syringes) that contain polycarbonate or ABS can dissolve when coming into contact with dimethylacetamide.[14]



Regulation


In 2011, dimethylacetamide was identified in the EU as a Substance of very high concern (SVHC) because of its reproductive toxicity.[15] In 2014, the European Commission has started an investigation to restrict the use of dimethylacetamide in the EU according to REACH.[16]


In 2015, the CNESST (Committee on Standards, Equity, Health and Safety at Work in Quebec) has adopted a tightened classification of dimethylacetamide:[17]






































Description Category
GHS hazard statement
Reproductive toxicity 2 Suspected of damaging fertility or the unborn child (H361)
Specific target organ toxicity - repeated exposure 2 May cause damage to organs through prolonged or repeated exposure (H373)
Serious eye damage/eye irritation 2 Causes serious eye irritation (H319)
Acute toxicity - inhalation 3 Toxic if inhaled (H331)
Specific target organ toxicity - single exposure - narcotic effects 3 May cause drowsiness or dizziness (H336)
Flammable liquid 4 Combustible liquid (H227)


References





  1. ^ Munro, D. D.; Stoughton, R. B. (1965). "Dimethylacetamide (DMAC) and Dimethylformamide (DMFA). Effect on Percutaneous Absorption". Archives of Dermatology. 92 (5): 585–586. doi:10.1001/archderm.1965.01600170101020. PMID 5844405..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"""""""'""'"}.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}


  2. ^ Iloukhani, H., and K. Khanlarzadeh. "Densities, viscosities, and refractive indices for binary and ternary mixtures of N, N-dimethylacetamide (1)+ 2-methylbutan-2-ol (2)+ ethyl acetate (3) at 298.15 K for m liquid region and at ambient pressure." Journal of Chemical & Engineering Data 51.4 (2006): 1226-1231. doi:10.1021/je050538q


  3. ^ abc "NIOSH Pocket Guide to Chemical Hazards #0218". National Institute for Occupational Safety and Health (NIOSH).


  4. ^ ab "Dimethyl acetamide". Immediately Dangerous to Life and Health Concentrations (IDLH). National Institute for Occupational Safety and Health (NIOSH).


  5. ^ ab Cheung, H.; Tanke, R. S.; Torrence, G. P., "Acetic Acid", Ullmann's Encyclopedia of Industrial Chemistry, Weinheim: Wiley-VCH, doi:10.1002/14356007.a01_045.pub2CS1 maint: Multiple names: authors list (link)


  6. ^ Zen, S.; Kaji, E. (1977). "Dimethyl nitrosuccinate". Organic Syntheses. 57: 60.CS1 maint: Multiple names: authors list (link); Collective Volume, 6, p. 503


  7. ^ European Chemicals Agency, Opinion on N,N-Dimethylacetamide (DMAC), 12 September 2014


  8. ^ ab U.S. Department of Health and Human Services & U.S. Department of Labor (1978) Occupational Health Guideline for Dimethyl Acetamide. Now: Occupational Health Guideline for Chemical Hazards. DHHS (NIOSH) Publication Number 81-123. January 1981. The National Institute for Occupational Safety and Health (NIOSH).


  9. ^ Baum, S. L.; Suruda, A. J. (1997). "Toxic Hepatitis from Dimethylacetamide". International Journal of Occupational and Environmental Health. 3 (1): 1–4. doi:10.1179/oeh.1997.3.1.1. PMID 9891094.


  10. ^ Lee, C.-Y.; Jung, S.-J.; Kim, S.-A.; Park, K.-S.; Ha, B.-G. (2006). "Incidence of dimethylacetamide induced hepatic injury among new employees in a cohort of elastane fibre workers". Occupational and Environmental Medicine. 63 (10): 688–693. doi:10.1136/oem.2005.023580. PMC 2078052. PMID 16728503.


  11. ^ Gong, W.; Liu, X.; Zhu, B. (2016). "Dimethylacetamide-induced occupational toxic hepatitis with a short term recurrence: a rare case report". Journal of Thoracic Disease. 8 (6): E408–E411. doi:10.21037/jtd.2016.04.44. PMC 4885965. PMID 27293868.


  12. ^ Weiss, A. J.; Jackson, L. G.; Carabasi, R. A.; Mancall, E. L.; White, J. C. (1962). "A Phase I Study of Dimethylacetamide". Cancer Chemotherapy Reports. 16 (February 1962): 477–485. PMID 14005853.


  13. ^ Weiss, A. J.; Mancall, E. L.; Koltes, J. A.; White, J. C.; Jackson, L. G. (1962). "Dimethylacetamide: A Hitherto Unrecognized Hallucinogenic Agent". Science. 136 (3511): 151–152. doi:10.1126/science.136.3511.151. PMID 14005854.


  14. ^ FDA warns health care professionals not to use Treanda Injection (solution) with closed system transfer devices, adapters, and syringes containing polycarbonate or acrylonitrile-butadiene-styrene – 10 March 2015


  15. ^ Agreement of the Member State Committee on the Identification of N,N-Dimethylacetamide (DMAC) as a Substance of Very High Concern – Adopted on 24 November 2011


  16. ^ Official Journal of the European Union, 19.8.2014, Commission Regulation (EU) No 895/2014


  17. ^ Commission des normes, de l'équité, de la santé et de la sécurité du travail (CNESST), Quebec, Canada: WHMIS 2015 classification of N,N-Dimethylacetamide




External links



  • Process flowsheet of Dimethylacetamide Production from Acetic Acid and Dimethylamine

  • CDC - NIOSH Pocket Guide to Chemical Hazards




Popular posts from this blog

Shashamane

Carrot

Deprivation index